Stay updated on Comparing GA-GCB ERT With Imiglucerase in GD Clinical Trial
Sign up to get notified when there's something new on the Comparing GA-GCB ERT With Imiglucerase in GD Clinical Trial page.

Latest updates to the Comparing GA-GCB ERT With Imiglucerase in GD Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe page’s footer/app revision indicator was updated from “Revision: v3.5.2” to “Revision: v3.5.3,” reflecting a backend/interface version change rather than any change to the study record.SummaryDifference0.1%

- Check27 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2. No user-facing content or functionality appears to change.SummaryDifference0.1%

- Check42 days agoChange DetectedGaucher disease type I has been added as a related condition term on the study page.SummaryDifference0.1%

- Check56 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3.SummaryDifference0.1%

- Check63 days agoChange DetectedRevision: v3.4.3 was added, replacing the previous v3.4.2.SummaryDifference0.1%

- Check92 days agoChange DetectedAdded Revision: v3.4.2 and removed the funding-status notice. The earlier Revision: v3.4.1 notice was also removed; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Comparing GA-GCB ERT With Imiglucerase in GD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Comparing GA-GCB ERT With Imiglucerase in GD Clinical Trial page.